How does ramucirumab help improve treatment outcomes for advanced gastric cancer (AGC) patients?
Ramucirumab is safe, effective, and well-tolerated across the intent-to-treat AGC patient populations and several pre-specified subgroups, including those whose disease is traditionally more challenging to treat.
Attend this exclusive webinar on 28th November 2022, at 3:30 and 9:30 PM IST, with our international and national gastric cancer experts, Dr. Abdullah Alsharm (KSA), Prof. Stefano Cascinu (Italy), Dr. Akhil Kapoor (India), Ms. Lucy Eldridge (UK), and Dr. Nouri Bennini (UAE), as they discuss the role of Ramuricumab in AGC treatment and the updated European Society for Medical Oncology (ESMO) guidelines for continuum care in AGC.
No comments:
Post a Comment